Search Results

You are looking at 1 - 1 of 1 items for :

  • "gut hormone multi-agonists" x
  • Refine by access: All content x
Clear All
Xianxian Huang Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, China

Search for other papers by Xianxian Huang in
Google Scholar
PubMed
Close
,
Jing Liu Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, China

Search for other papers by Jing Liu in
Google Scholar
PubMed
Close
,
Guangquan Peng Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, China

Search for other papers by Guangquan Peng in
Google Scholar
PubMed
Close
,
Mingyue Lu Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, China

Search for other papers by Mingyue Lu in
Google Scholar
PubMed
Close
,
Zhongbo Zhou School of Pharmacy, Youjiang Medical University for Nationalities, Baise, Guangxi, China

Search for other papers by Zhongbo Zhou in
Google Scholar
PubMed
Close
,
Neng Jiang Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, China

Search for other papers by Neng Jiang in
Google Scholar
PubMed
Close
, and
Zhiming Yan Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, China

Search for other papers by Zhiming Yan in
Google Scholar
PubMed
Close

, arthritis, neurodegenerative disorders, and certain cancers ( Fig. 2 ). Revolutionizing treatment: gut hormone multi-agonist therapy Over the past decade, ongoing clinical research on GLP-1RAs has revolutionized the fields of glucoregulation and

Restricted access